Francesca Bagnato1, Clelia Pellicano1,
Fredric Cantor1, Antonio Gallo1, Sungyoung Auh2,
Mary Ehrmantraut1, Iordanis Evangelou1, Vasiliki
Ikonomidou1, Robert Kane3, Joan Ohayon1,
Susan Stern1, Henry McFarland1
1NIB-NINDS-NIH, Bethesda, MD, United
States; 2Clinical Director Office-NINDS-NIH, Bethesda, MD, United
States; 3VA, Baltimore
Pathophysiological
mechanisms underlying the development of depression in patients with multiple
sclerosis (MS) remain unknown. We here demonstrate that atrophy of deep grey
matter (GM) structures of the limbic circuit, such as thalamus and hippocampus,
may explain up to 30% of the variance of depression in MS. The relation
between depression and GM atrophy holds significant when the effect of
patients physical disability is taken into account. The results highlight
the role of neurodegeneration in specific brain sites as an important factor
associated with depression in MS patients.